Æterna Zentaris to Present at BioContact in Quebec City on October 8
QUÉBEC CITY,
About Æterna Zentaris Inc.
Æterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.
For further information: Investor Relations: Ginette Vallières, Investor Relations Coordinator, (418) 652-8525 ext. 265, [email protected]; Media Relations: Paul Burroughs, Director of Communications, (418) 652-8525 ext. 406, [email protected]
Share this article